Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.
Nat Immunol. 2022 Feb;23(2):210-216. doi: 10.1038/s41590-021-01113-x. Epub 2022 Jan 13.
Nat Immunol. 2022.
PMID: 35027728